Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi-Center Real-Life Study

被引:0
作者
Picardi, M. [1 ]
Vincenzi, A. [1 ]
Giordano, C. [1 ]
De Fazio, L. [1 ]
Pugliese, N. [1 ]
Scarpa, A. [1 ]
Vigliar, E. [2 ]
Troncone, G. [2 ]
Russo, D. [3 ]
Mascolo, M. [3 ]
Esposito, G. [3 ]
Prastaro, M. [3 ]
Santoro, C. [3 ]
Esposito, R. [1 ]
Tocchetti, C. G. [4 ]
Mainolfi, C. [3 ]
Fonti, R. [3 ]
Vecchio, S. Del [3 ]
Carchia, M. [2 ]
Quagliano, C. [1 ]
Salemme, A. [1 ]
Damiano, V. [1 ]
Bianco, R. [1 ]
Trastulli, F. [5 ]
Ronconi, F. [5 ]
Annunziata, M. [5 ]
Pane, F. [1 ]
机构
[1] Univ Naples Federico II, Dept Clin Med & Surg, Med Sch, Naples, Italy
[2] Univ Naples Federico II, Dept Publ Hlth, Med Sch Naples, Naples, Italy
[3] Univ Naples Federico II, Dept Adv Biomed Sci, Med Sch, Naples, Italy
[4] Univ Naples Federico II, Dept Translat Med Sci, Med Sch, Naples, Italy
[5] Antonio Cardarelli Hosp Natl Importance, Hematol Unit, Naples, Italy
关键词
c-HL; consolidation radiotherapy; elderly patients; MVD; non-pegylated liposomal doxorubicin; CORE-NEEDLE BIOPSY; RESPONSE ASSESSMENT; MANAGEMENT; RADIATION; LYMPHADENOPATHIES; BLEOMYCIN; CYCLES; TRIAL;
D O I
10.1002/hon.70003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In elderly patients with high-risk classic Hodgkin lymphoma (c-HL), we evaluated the impact of a new modality treatment without bleomycin, that is, liposomal doxorubicin (NPLD)-based regimen plus consolidation radiotherapy of residual nodal masses (RNMs), on overall survival (OS) and progression free survival (PFS). In this retrospective study (2013-2023) conducted in tertiary hospitals in the bay of Naples (Italy), 50 older adults (median age, 69 years; range, 60-89) with advanced stage c-HL received frontline treatment with MVD +/- irradiation. MVD consisted of 25 mg/m2 of NPLD along with standard Vinblastine and Dacarbazine for a total of 6 cycles (twelve iv administrations, every 2 weeks) followed by radiation of RNMs with size >= 2.5 cm at computed tomography. Patients underwent MVD with a median dose intensity of 92%. At 2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography (FDG-PET), 90% of patients (45/50 patients; one failed to perform final FDG-PET due to early death) reached complete responses. Altogether, 17 patients (34%) received consolidation radiotherapy of RNMs with Deauville score >= 3. At 5-year median follow-up, the OS and PFS of the entire population were 87.5% (95% confidence interval [CI], 78.7-97.4) and 81.6% (95% CI, 71.4-93.2), respectively. Eleven patients (22%) experienced grade >= 3 adverse events, and 4 of them required hospitalization. Our data suggest that in older adults with high-risk c-HL NPLD-driven strategy (without bleomycin) plus consolidation radiotherapy (if needed) may be a promising up-front option, to test in phase II clinical trials for improving survival incidence.
引用
收藏
页数:13
相关论文
共 42 条
[1]   Current Strategies to Target Tumor-Associated-Macrophages to Improve Anti-Tumor Immune Responses [J].
Anfray, Clement ;
Ummarino, Aldo ;
Torres Andon, Fernando ;
Allavena, Paola .
CELLS, 2020, 9 (01)
[2]   Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma [J].
Ansell, Stephen M. ;
Radford, John ;
Connors, Joseph M. ;
Dlugosz-Danecka, Monika ;
Kim, Won-Seog ;
Gallamini, Andrea ;
Ramchandren, Radhakrishnan ;
Friedberg, Jonathan W. ;
Advani, Ranjana ;
Hutchings, Martin ;
Evens, Andrew M. ;
Smolewski, Piotr ;
Savage, Kerry J. ;
Bartlett, Nancy L. ;
Eom, Hyeon-Seok ;
Abramson, Jeremy S. ;
Dong, Cassie ;
Campana, Frank ;
Fenton, Keenan ;
Puhlmann, Markus ;
Straus, David J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (04) :310-320
[3]   Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].
Barrington, Sally F. ;
Mikhaeel, N. George ;
Kostakoglu, Lale ;
Meignan, Michel ;
Hutchings, Martin ;
Mueeller, Stefan P. ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Fisher, Richard I. ;
Trotman, Judith ;
Hoekstra, Otto S. ;
Hicks, Rodney J. ;
O'Doherty, Michael J. ;
Hustinx, Roland ;
Biggi, Alberto ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+
[4]   Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper [J].
Busca, Alessandro ;
Cattaneo, Chiara ;
De Carolis, Elena ;
Nadali, Gianpaolo ;
Offidani, Massimo ;
Picardi, Marco ;
Candoni, Anna ;
Ceresoli, Eleonora ;
Criscuolo, Marianna ;
Delia, Mario ;
Della Pepa, Roberta ;
Del Principe, Ilaria ;
Fanci, Roma Rosa ;
Farina, Francesca ;
Fracchiolla, Nicola ;
Giordano, Claudia ;
Malagola, Michele ;
Marchesi, Francesco ;
Piedimonte, Monica ;
Prezioso, Lucia ;
Quinto, Angela Maria ;
Spolzino, Angelica ;
Tisi, Maria Chiara ;
Trastulli, Fabio ;
Trecarichi, Enrico Maria ;
Zappasodi, Patrizia ;
Tumbarello, Mario ;
Pagano, Livio .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 158
[5]   Modeling the risk of radiation-induced lung fibrosis: Irradiated heart tissue is as important as irradiated lung [J].
Cella, Laura ;
D'Avino, Vittoria ;
Palma, Giuseppe ;
Conson, Manuel ;
Liuzzi, Raffaele ;
Picardi, Marco ;
Pressello, Maria Cristina ;
Boboc, Genoveva Ionela ;
Battistini, Roberta ;
Donato, Vittorio ;
Pacelli, Roberto .
RADIOTHERAPY AND ONCOLOGY, 2015, 117 (01) :36-43
[6]   The outcome of older adults with classic Hodgkin lymphoma in British Columbia [J].
Cheng, Phoebe T. M. ;
Villa, Diego ;
Gerrie, Alina S. ;
Freeman, Ciara L. ;
Slack, Graham W. ;
Gascoyne, Randy D. ;
Farinha, Pedro ;
Craig, Jeffrey W. ;
Skinnider, Brian ;
Wilson, Don ;
Scott, David W. ;
Connors, Joseph M. ;
Sehn, Laurie H. ;
Savage, Kerry J. .
BLOOD ADVANCES, 2022, 6 (22) :5924-5932
[7]   Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].
Cheson, Bruce D. ;
Fisher, Richard I. ;
Barrington, Sally F. ;
Cavalli, Franco ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Lister, T. Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+
[8]  
COWENS JW, 1993, CANCER RES, V53, P2796
[9]   Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Eichenauer, D. A. ;
Aleman, B. M. P. ;
Andre, M. ;
Federico, M. ;
Hutchings, M. ;
Illidge, T. ;
Engert, A. ;
Ladetto, M. .
ANNALS OF ONCOLOGY, 2018, 29 :19-29
[10]   Hodgkin's lymphoma in elderly patients:: A comprehensive retrospective analysis from the German Hodgkin's Study Group [J].
Engert, A ;
Ballova, V ;
Haverkamp, H ;
Pfistner, B ;
Josting, A ;
Dühmke, E ;
Müller-Hermelink, K ;
Diehl, V .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5052-5060